TCIM
BPMC

TIAA CREF Investment Management’s Blueprint Medicines BPMC Stock Holding History

TIAA CREF Investment Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.51M Sell
93,861
-1,378
-1% -$102K 0.01% 1204
2018
Q4 		$5.13M Sell
95,239
-2,722
-3% -$165K ﹤0.01% 1360
2018
Q3 		$7.65M Sell
97,961
-7,892
-7% -$549K 0.01% 1283
2018
Q2 		$6.72M Sell
105,853
-9,269
-8% -$738K ﹤0.01% 1399
2018
Q1 		$10.6M Sell
115,122
-509
-0.4% -$43.9K 0.01% 1086
2017
Q4 		$8.72M Sell
115,631
-1,665
-1% -$117K 0.01% 1217
2017
Q3 		$8.17M Sell
117,296
-4,645
-4% -$248K 0.01% 1278
2017
Q2 		$6.18M Buy
121,941
+58,513
+92% +$2.48M ﹤0.01% 1460
2017
Q1 		$2.54M Buy
63,428
+5,795
+10% +$208K ﹤0.01% 1993
2016
Q4 		$1.62M Sell
57,633
-5,596
-9% -$169K ﹤0.01% 2297
2016
Q3 		$1.88K Sell
63,229
-838
-1% -$20.8K ﹤0.01% 2213
2016
Q2 		$1.3M Buy
64,067
+32,361
+102% +$588K ﹤0.01% 2386
2016
Q1 		$572K Hold
31,706
– – ﹤0.01% 2746
2015
Q4 		$835K Hold
31,706
– – ﹤0.01% 2685
2015
Q3 		$677K Sell
31,706
-20,360
-39% -$563K ﹤0.01% 2789
2015
Q2 		$1.38M Buy
+52,066
New +$1.49M ﹤0.01% 2518

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TIAA CREF Investment Management's BPMC Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Blueprint Medicines (BPMC) stake by 1.4% in Q1 2019, selling an estimated $102K and leaving 93,861 shares worth $7.51M. The position accounts for 0.01% of the portfolio, ranked #1204.

TIAA CREF Investment Management first reported a position in BPMC in Q2 2015 and has held it in 16 quarters since. The position peaked at $10.6M in Q1 2018. 203 funds tracked by Wall St. Rank hold BPMC as of Q1 2019.

  • TIAA CREF Investment Management held 93,861 shares of Blueprint Medicines worth $7.51M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,378 Blueprint Medicines shares in Q1 2019, an estimated $102K.
  • Blueprint Medicines made up 0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1204 holding.
  • TIAA CREF Investment Management first reported a position in Blueprint Medicines in Q2 2015 and has held it in 16 quarters since.
  • TIAA CREF Investment Management's Blueprint Medicines position peaked at $10.6M in Q1 2018.
  • 203 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.